查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401004

Sprycel 市场，按人口统计、心理统计、行为、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Sprycel Market, By Demographic, By Psychographic, By Behavioral, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 296 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年 Sprycel 市场规模为 54.7 亿美元，2023 年至 2030 年复合CAGR为 5.2%。

Sprycel 市场-市场动态

它针对特定癌症相关蛋白（称为酪氨酸激酶）的功效推动了市场需求

精准医学根据患者的遗传和分子特征量身定制治疗方案，从而产生了标靶治疗。达沙替尼（Dasatinib）就是这种技术的一个例子，它正在被开发用于治疗慢性骨髓性白血病（CML）和费城染色体阳性急性淋巴细胞白血病（Ph+ ALL）。 Sprycel 透过降低酪胺酸激酶的活性来中断驱动癌细胞发育的信号通路，为标准化疗提供更有效且毒性更低的替代方案，从而改善患有这些疾病的患者的预后。

Sprycel 市场 - 关键见解

根据我们的研究分析师分享的分析，全球 Sprycel 市场预计在预测期内（2023-2030 年）每年将以 5.2% 左右的CAGR成长

Sprycel 产业预计将以显着的速度成长，因为它能有效靶向特定的癌症相关蛋白（称为酪胺酸激酶）。

根据人口统计细分，Age 预计将在 2022 年显示最大的市场份额

根据心理细分，生活方式是 2022 年领先的人口统计

按地区划分，亚太地区是 2022 年领先的收入来源

Sprycel 市场-細項分析：

全球 Sprycel 市场根据人口统计、心理统计、行为和区域进行细分。

市场依人口统计分为四个类别：年龄、性别、收入。年龄细分市场占据主导地位。 Sprycel（达沙替尼）的需求很大程度上是由其用于治疗老年人中更常见的特定类型白血病的用途所推动的。慢性骨髓性白血病 (CML) 和费城染色体阳性急性淋巴细胞白血病 (Ph+ ALL) 在老年人群中越来越常见，这增加了对 Sprycel 等标靶药物的需求。

市场依心理分为两类：生活方式、态度。生活方式产业在市场中占据主导地位，并可能在预测期内保持其主导地位。 Sprycel（达沙替尼）生活方式需求通常包括人们改变习惯以适应治疗。为了控制可能的副作用，患者可能需要坚持常规处方疗法并改变饮食和运动。在接受 Sprycel 药物治疗时，通常会优先考虑促进整体健康的生活方式。

Sprycel 市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。受多种变数影响，亚太地区 Sprycel（达沙替尼）需求持续成长。由于人口膨胀和老化，该地区慢性骨髓性白血病（CML）和费城染色体阳性急性淋巴细胞白血病（Ph+ ALL）等血液系统恶性肿瘤的发生率增加。其次，医疗保健基础设施、诊断技术和创新疗法的可用性的进步提高了人们对复杂治疗的认识和需求。第三，亚太地区不断扩大的製药业和研究合作伙伴关係使 Sprycel 等标靶药物变得更容易获得。这些因素导致该地区对 Sprycel 的强劲需求，为与这些危及生命的疾病作斗争的患者带来了希望。

Sprycel 市场-竞争格局：

几家主要公司在血液恶性肿瘤酪胺酸激酶抑制剂的竞争格局中占据主导地位，其中包括 Sprycel（达沙替尼）。 Sprycel 的製造商百时美施贵宝 (Bristol Myers Squibb) 拥有相当大的市场份额。然而，竞争来自于生产类似药物的其他製药公司，例如伊马替尼和尼洛替尼。持续的研究努力有助于创造更有效、更有针对性的此类药物。此外，这些药物的仿製药透过为患者提供更多的成本选择而对市场产生影响。竞争环境鼓励创新，并确保白血病及相关疾病患者能获得多种治疗选择。

目录

第 1 章：Sprycel 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按人口统计的 Sprycel 市场片段
    • Psychographic 的 Sprycel 市场片段
    • 按行为分類的 Sprycel 市场片段
    • 按国家/地区分類的 Sprycel 市场片段
    • 按地区分類的 Sprycel 市场片段
  • 竞争洞察

第 3 章：Sprycel 主要市场趋势

  • Sprycel 市场驱动因素
    • 市场驱动因素的影响分析
  • Sprycel 市场限制
    • 市场限制影响分析
  • Sprycel 市场机会
  • Sprycel 市场未来趋势

第 4 章：Sprycel 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：Sprycel 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：Sprycel 市场格局

  • 2022 年 Sprycel 市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：Sprycel 市场 - 按人口统计

  • 概述
    • 按人口统计分類的细分市场占有率分析
    • 年龄
    • 性别
    • 收入

第 8 章：Sprycel 市场 - 透过 Psychographic

  • 概述
    • 细分市场占有率分析（依心理分析）
    • 生活方式
    • 态度

第 9 章：Sprycel 市场 - 按行为分类

  • 概述
    • 按行为分類的细分市场占有率分析
    • 使用率
    • 遵守
    • 治疗史

第 10 章：Sprycel 市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • Sprycel 北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按人口统计）
    • 北美市场规模与预测（按心理分析）
    • 北美市场规模与预测（按行为）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • Sprycel 欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按人口统计）
    • 欧洲市场规模与预测（按心理分析）
    • 欧洲市场规模与预测（按行为）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • Sprycel 亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依人口统计）
    • 亚太地区市场规模与预测（依心理分析）
    • 亚太地区市场规模与预测（按行为）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • Sprycel 拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按人口统计）
    • 拉丁美洲市场规模与预测（按心理分析）
    • 拉丁美洲市场规模与预测（按行为）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • Sprycel 中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按人口统计）
    • 中东和非洲市场规模及预测（按心理分析）
    • 中东和非洲市场规模及预测（按行为）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - Sprycel 产业

  • 竞争仪表板
  • 公司简介
    • Bristol-Myers Squibb (BMS)
    • Novartis
    • Teva Pharmaceutical Industries
    • Mylan
    • Accord Healthcare
    • Sun Pharma
    • Dr Reddy's Laboratories
    • Aurobindo Pharma
    • LUCIUS Pharma

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1968

REPORT HIGHLIGHT

Sprycel Market size was valued at USD 5,470 Million in 2022, expanding at a CAGR of 5.2% from 2023 to 2030.

Sprycel (dasatinib) is a prescription drug used to treat some kinds of leukemia as well as other blood diseases. It belongs to the tyrosine kinase inhibitor family of medicines. Sprycel works by inhibiting the function of particular proteins involved in cancer cell proliferation and spread. This drug is used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). It is normally administered orally and plays an important role in treating certain hematologic malignancies, improving patient outcomes, and slowing disease progression.

Sprycel Market- Market Dynamics

Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases propel market demand

Precision medicine, which tailor's therapies based on a patient's genetic and molecular profile, has resulted in targeted therapy. Dasatinib, which is being developed as a therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), is an example of this technique. Sprycel interrupts the signaling pathways that drive cancer cell development by reducing the activity of tyrosine kinases, providing a more effective and less toxic alternative to standard chemotherapy and thereby improving the prognosis for patients with these illnesses.

Sprycel Market- Key Insights

As per the analysis shared by our research analyst, the global Sprycel market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2023-2030)

The Sprycel industry is projected to grow at a significant rate due to Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases.

Based on Demographic segmentation, Age was predicted to show maximum market share in the year 2022

Based on Psychographic segmentation, Lifestyle was the leading Demographic in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Sprycel Market- Segmentation Analysis:

The Global Sprycel Market is segmented on the basis of Demographic, Psychographic, Behavioral, and Region.

The market is divided into four categories based on Demographic: Age, Gender, Income. The Age segment dominates the market. Sprycel (dasatinib) demand is largely driven by its usage in treating particular types of leukaemia that are more common in older persons. Chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) are becoming increasingly frequent in the elderly population, increasing need for targeted medicines such as Sprycel.

The market is divided into two categories based on Psychographic: Lifestyle, Attitudes. The Lifestyle sector dominates the market and is likely to maintain its dominance during the forecast period. Sprycel (dasatinib) lifestyle demand generally consists of people modifying their habits to accommodate therapy. To manage possible side effects, patients may need to stick to a regular prescription regimen and adopt dietary and exercise changes. While receiving Sprycel medication, lifestyle decisions that promote general well-being are often prioritized.

Sprycel Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Sprycel (dasatinib) demand in the Asia-Pacific area has been continuously growing due to a variety of variables. Owing to population expansion and aging, the area has seen an increase in the frequency of hematological malignancies such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Second, advances in healthcare infrastructure, diagnostics, and the availability of innovative therapeutics have increased awareness of and demand for sophisticated treatments. Third, the Asia-Pacific region's expanding pharmaceutical sector and research partnerships are making targeted medicines like Sprycel more accessible. These factors contribute to the region's strong demand for Sprycel, giving patients fighting these life-threatening illnesses hope.

Sprycel Market- Competitive Landscape:

Several main companies dominate the competitive landscape of tyrosine kinase inhibitors for hematological malignancies, including Sprycel (dasatinib). Sprycel's maker, Bristol Myers Squibb, has a substantial market share. However, competition comes from other pharmaceutical firms that manufacture comparable medications, such as imatinib and nilotinib. Competition is aided by ongoing research efforts to create more effective and focused medicines in this class. Furthermore, generic versions of these drugs have an impact on the landscape by offering patients with more cost choices. The competitive environment encourages innovation and guarantees that patients with leukaemia and associated illnesses have access to a variety of treatment alternatives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SPRYCEL MARKET KEY PLAYERS

  • Bristol-Myers Squibb (BMS)
  • Novartis
  • Teva Pharmaceutical Industries
  • Mylan
  • Accord Healthcare
  • Sun Pharma
  • Dr Reddy's Laboratories
  • Aurobindo Pharma
  • LUCIUS Pharma

GLOBAL SPRYCEL MARKET, BY DEMOGRAPHIC

  • Age
  • Gender
  • Income

GLOBAL SPRYCEL MARKET, BY PSYCHOGRAPHIC

  • Lifestyle
  • Attitudes

GLOBAL SPRYCEL MARKET, BY BEHAVIORAL

  • Usage Rate
  • Compliance
  • Treatment History

GLOBAL SPRYCEL MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sprycel Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sprycel Market Snippet by Demographic
    • 2.1.2. Sprycel Market Snippet by Psychographic
    • 2.1.3. Sprycel Market Snippet by Behavioral
    • 2.1.4. Sprycel Market Snippet by Country
    • 2.1.5. Sprycel Market Snippet by Region
  • 2.2. Competitive Insights

3. Sprycel Key Market Trends

  • 3.1. Sprycel Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sprycel Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sprycel Market Opportunities
  • 3.4. Sprycel Market Future Trends

4. Sprycel Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sprycel Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sprycel Market Landscape

  • 6.1. Sprycel Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sprycel Market - By Demographic

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Demographic, 2022 & 2030 (%)
    • 7.1.2. Age
    • 7.1.3. Gender
    • 7.1.4. Income

8. Sprycel Market - By Psychographic

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Psychographic, 2022 & 2030 (%)
    • 8.1.2. Lifestyle
    • 8.1.3. Attitudes

9. Sprycel Market - By Behavioral

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Behavioral, 2022 & 2030 (%)
    • 9.1.2. Usage Rate
    • 9.1.3. Compliance
    • 9.1.4. Treatment History

10. Sprycel Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Sprycel Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Sprycel Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Sprycel Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Sprycel Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Sprycel Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Sprycel Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Bristol-Myers Squibb (BMS)
    • 11.2.2. Novartis
    • 11.2.3. Teva Pharmaceutical Industries
    • 11.2.4. Mylan
    • 11.2.5. Accord Healthcare
    • 11.2.6. Sun Pharma
    • 11.2.7. Dr Reddy's Laboratories
    • 11.2.8. Aurobindo Pharma
    • 11.2.9. LUCIUS Pharma

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Psychographics
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sprycel Market: Demographic Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Demographic
  • TABLE Global Sprycel Market, by Demographic 2018-2030 (USD Million)
  • TABLE Sprycel Market: Psychographic Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Psychographic
  • TABLE Global Sprycel Market, by Psychographic 2018-2030 (USD Million)
  • TABLE Sprycel Market: Behavioral Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Behavioral
  • TABLE Global Sprycel Market, by Behavioral 2018-2030 (USD Million)
  • TABLE Sprycel Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sprycel Market, by Region 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Behavioral, 2018-2030 (USD Million)